![[Industry Direct] PHI Studio & Agog Are Seeking Immersive Artists for a Four Week Residency Program](https://roadtovrlive-5ea0.kxcdn.com/wp-content/uploads/2025/05/phi-immersive-residency-2-341x220.jpg?#)
FDA adcomm to review Capricor's Duchenne cell therapy
Capricor Therapeutics' cell therapy for Duchenne muscular dystrophy will face an FDA advisory committee ahead of an approval decision that's expected Aug. 31, the company disclosed on Monday. The San Diego-based company, which saw its ...
Capricor Therapeutics' cell therapy for Duchenne muscular dystrophy will face an FDA advisory committee ahead of an approval decision that's expected Aug. 31, the company disclosed on Monday.
The San Diego-based company, which saw its ...
